510(k) Report

510(k) · Cleared

Cleared

Fossa Ureteral Open Stents

K072293510(k) TraditionalCleared Aug 6, 2008356-day reviewClass II21 CFR 876.4620

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fossa Medical, Inc. · FAD Stent, Ureteral

Cleared on Aug 6, 2008 as substantially equivalent to K033368 (Fossa Medical, Inc., 2003) and 1 other predicate after a 356-day review. Its family tree reaches back 3 generations to 2002.

Decided
Aug 6, 2008
Review
356 days
Class
Class II
Product code
FAD
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K021602 (2002). 4 ancestors in all, the oldest K021140 (2002). No later device cites it as a predicate yet.

  1. Root · 3 generations backK021602 Fossa Ureteral Stone SweeperFossa Industries, Inc. · 2002
  2. 2 generations backK031292 Modification to Fossa Ureteral Stone SweeperFossa Medical, Inc. · 2003
  3. 1 generation backK033368 Fossa Ureteral Open Lumen StentFossa Medical, Inc. · 2003
  4. This deviceK072293 Fossa Ureteral Open StentsFossa Medical, Inc. · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K021602Fossa Ureteral Stone SweeperFossa Industries, Inc.2002—
−2K031292Modification to Fossa Ureteral Stone SweeperFossa Medical, Inc.2003—
−1K033368Fossa Ureteral Open Lumen StentFossa Medical, Inc.2003—
0 (this device)K072293Fossa Ureteral Open StentsFossa Medical, Inc.2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210
FIG. 1 — Lineage of K072293, 2002–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FAD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FAD device

  1. #1 K251890 Disposable Ureteral Stentsscore 12.4 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K033368Fossa Ureteral Open Lumen Stent
Summary page 1
…Performance Standards (78FAD), and is classified under 21 CFR 876.4620. Predicate Devices: Fossa Open Lumen Stent (K033368) Fossa Double Pigtail Expanding Ureteral Stent (K021140) Product Description: The Fossa Ureteral O…
Fossa Medical, Inc.2003—
*K021140Fossa Expanding Double Pigtail Ureteral Stent
Summary page 1
…21 CFR 876.4620. Predicate Devices: Fossa Open Lumen Stent (K033368) Fossa Double Pigtail Expanding Ureteral Stent (K021140) Product Description: The Fossa Ureteral Open-8 Stent set consists of a flexible, pigtail-tipped stent with a radiopaque push ca…
Fossa Industries, Inc.2002—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 2 companies; a new generation was cleared every 10 months on median.
  • None of the 4 ancestors has a recall.

How does its category compare?

All FAD devices

FAD Stent, Ureteral: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · FAD

4in 2025

2007: 12008: 12010: 12014: 12016: 42017: 82018: 92019: 52020: 12021: 22022: 52024: 12025: 42026 (partial year): 1
2007high 9 (2018) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FAD

186in 2025

2016: 143 days median2017: 266 days median2018: 258 days median2019: 263 days median2022: 143 days median2025: 186 days median
2007high 266 (2017) · low 143 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FAD

4in 2025

2007: 12008: 222009: 22010: 12016: 42019: 62020: 22021: 12022: 92025: 4
2007high 22 (2008) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FAD

634in 2025

2007: 432008: 762009: 1232010: 782011: 952012: 1312013: 822014: 782015: 1302016: 1822017: 2652018: 2772019: 2612020: 3522021: 5312022: 5592023: 6912024: 6032025: 634
2007high 691 (2023) · low 43 (2007)2025

MAUDE reports naming product code FAD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—143
20081—2276
20090—2123
20101—178
20110—095
20120—0131
20130—082
20141—078
20150—0130
201641434182
201782660265
201892580277
201952636261
20201—2352
20212—1531
202251439559
20230—0691
20241—0603
202541864634
20261—0—

What is it indicated for?

The OPEN-8 Stent is indicated for use as an indwelling ureteral catheter to

promote drainage of urine from the kidney to the bladder.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072293: Fossa Ureteral Open Stents.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K072293

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026